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Aluminium foil as a single-use substrate for
MALDI-MS ﬁngerprinting of diﬀerent
melanoma cell lines†
A. Bondarenko,a Y. Zhu,a L. Qiao,a F. Cortés Salazar,a H. Pickb and H. H. Girault*a
Herein, we present the intact cell matrix-assisted laser desorption/ionization mass spectrometry
(MALDI-MS) for the ﬁngerprinting of human melanoma cancer cell lines grown on aluminium foil. To
perform the MALDI-MS assay, melanoma cells were cultured on a ﬂat and thin foil, which was directly
transferred to the target plate of MALDI-MS for analysis. The inﬂuence of a wide range of cell ﬁxation pro-
tocols (i.e. formalin-based and alcohol-based methods) and MALDI matrices on the obtained character-
istic spectra was investigated. For the optimization of the MALDI-MS protocol, the MS ﬁngerprints of the
melanoma WM-239 cell line with and without an overexpressed enhanced green ﬂuorescent protein
were employed. The ﬁngerprints obtained from WM-239 cells grown on aluminium foil were compared
with the intact cell MALDI-MS of the cell pellet and presented higher sensitivity in a high m/z range. The
optimized protocol was subsequently applied to characterise melanoma cell lines derived from diﬀerent
cancer stages and allowed identiﬁcation of unique MS signals that could be used for diﬀerentiation
between the studied cell lines (i.e. molecular weight equal to 10.0 kDa and 26.1 kDa).
Introduction
Mammalian cells cultured in vitro have been widely employed
in medicine and biology as a simple model of complex
living organisms to develop new strategies for diagnosis and
treatment of diﬀerent diseases.1–4 With this aim various
approaches to characterize cells have been developed based on
chemical sensing, optical microscopy and mass-spectrometry
(MS).5–9 In comparison with other strategies, MS is a label free
technique where the analytical signal depends on the mole-
cular weight and charge of the analysed species after ioniza-
tion. Typically, MS experiments for the characterization of
in vitro cultured cells include cell lysis followed by the MS ana-
lysis of the obtained extract with or without enzymatic protein
cleavage.10 However, the full cell proteome analysis is very chal-
lenging and therefore, MS is often combined with separation
techniques, i.e. electrophoresis or liquid chromatography.11 To
ionize cellular constituents without fragmentation, soft ioniza-
tion techniques, e.g. electrospray ionization (ESI)12 and matrix-
assisted laser desorption/ionization (MALDI)13,14 are widely
used.15–18 Although these methods allow the detection and
identification of a wide range of proteins with high sensitivity,
they are complex and time-consuming.
Another approach for analysis of in vitro cultured mamma-
lian cells is the intact cell (IC) analysis, typically performed by
MALDI-MS. In this case, cells can be either grown directly on a
MALDI target plate19 or collected by centrifugation after cultur-
ing in a classical Petri dish.11,20–23 The latter allows cell pellets
to be either transferred directly to the target plate, where they
are dried and covered with a matrix solution,22,24 or mixed
with a matrix solution prior to the transfer.20,21,23,25,26 As a
result, instead of individual protein peaks, a number of
signals representing the MS fingerprint characteristic for a
specific cell type or physiological state can be obtained.11 This
approach has been successfully applied for the identification
of two diﬀerent pancreatic cell lines,22 the diﬀerentiation
between stimulated and non-stimulated macrophages,20 diﬀer-
entiation of toxic eﬀects generated by diﬀerent compounds,24
the prediction of mammalian cell phenotypes,21 the rapid
detection of apoptosis in mammalian cells,26 the monitoring
of histone deacetylase drug target engagement25 and the
characterization of neural cell types.23 Moreover, it was
reported that the analysis of on-target-grown cells resulted in
mass spectra of higher peak intensity in comparison with the
protocols with whole cells placed on top of a matrix layer
and with cellular extracts analysed using the conventional
†Electronic supplementary information (ESI) available. See DOI: 10.1039/
c6an00126b
aLaboratoire d’Electrochimie Physique et Analytique, École Polytechnique Fédérale de
Lausanne, EPFL Valais Wallis, CH-1951 Sion, Switzerland.
E-mail: hubert.girault@epfl.ch
bLaboratoire de Chimie Physique des Polymères et Membranes, École Polytechnique
Fédérale de Lausanne, 1015 Lausanne, Switzerland



















































. View Article Online
View Journal  | View Issue
sample-matrix mixture technique.19 However, it is important
to note that when culturing cells directly on MALDI target
plates the surface can be contaminated with high concen-
trations of salts present in the culturing medium, which nega-
tively influence the ionization eﬃciency. Furthermore, direct
sample washing with deionized water becomes diﬃcult due to
the strong osmotic pressure. In previous studies, this problem
was solved by chemical fixation of cells,27 which is a well-estab-
lished method in cell biology, histology and MALDI-MS
imaging of tissues28–30 and cells.31–33 Cells, treated in such a
way can be further washed without losing any intracellular
protein content.
Herein, we present an intact cell MALDI-MS protocol for
characterizing diﬀerences in the high-abundant protein
content of human melanoma cells derived from diﬀerent
cancer stages. With this aim, cells were grown in vitro and
chemically fixed on a flat and thin aluminium foil, which was
directly transferred to a MALDI target plate for MS analysis. As
a proof of concept and for optimization of the sample prepa-
ration, MS fingerprints of the melanoma WM-239 cell lines
with and without a recombinantly overexpressed enhanced
green fluorescent protein (EGFP) were recorded. Diﬀerent
chemical fixatives including cross-linkers (i.e. paraform-
aldehyde and paraformaldehyde–methanol) and dehydrators
(i.e. methanol, methanol–acetone and methanol–ethanol) were
tested and compared to the non-fixed cell samples. The opti-
mized protocol was subsequently applied to investigate mass
spectra diﬀerences between three melanoma cell lines, i.e.
Sbcl2, WM-115 and WM-239 corresponding to the radial
growth phase (RGP), vertical growth phase (VGP) and meta-
static melanoma stages, respectively.
Materials and methods
Chemicals
Trifluoroacetic acid (TFA) (99.0%) was obtained from Acros
Organics (New Jersey, USA). Cytochrome C (CytC), trypsin, 2,5-
dihydroxybenzoic acid (DHB), α-cyano-4-hydroxycinnamic acid
(HCCA) and sinapic acid (SA) were purchased from Sigma-
Aldrich (St Gallen, Switzerland). Methanol, acetone, ethanol
and acetonitrile were obtained from Merck (Dietikon, Switzer-
land) and formaldehyde solution (4% in PBS) was from Alfa-
Aesar (Karlsruhe, Germany). Deionized water was produced by
the Alpha Q Millipore system (Zug, Switzerland).
The matrices containing 10 mg per mL of SA, 10 mg per mL
of DHB or 10 mg per mL of HCCA were prepared in the solu-
tion containing 70% of acetonitrile, 29.9% of water and 0.1%
of TFA in terms of v/v.
WM-239, WM-115 and Sbcl2 human melanoma cell lines
were purchased from the American Type Culture Collection
(ATCC).
Cell culture preparation
Human melanoma cell lines WM-239, WM-115, and Sbcl2 as
well as WM-239 with overexpressed EGFP were cultured in Dul-
becco’s modified Eagle’s medium (Gibco Life Technologies,
Basel, Switzerland), supplemented with 10% fetal calf serum
at 37 °C in a humidified atmosphere with 5% CO2. Twenty
hours before the experiment, 200 μL of cell suspension (105
cells per mL) were placed on a sterile aluminium foil (∼1 cm
wide and ∼2 cm long) and incubated over 4 hours for attach-
ment on the surface (37 °C, 5% CO2). Finally, 2 mL of medium
was gently added into the system and the cells were incubated
overnight before starting the experiment (37 °C, 5% CO2). The
optical images of cell culturing steps are presented in ESI-I.†
In order to obtain WM-239 cells with overexpressed EGFP,
transient transfection was performed by using Lipofectamine
2000 (Invitrogen, Basel, Switzerland). Twenty hours before
transfection WM-239 cells were split in a 75 cm2 T-flask (TPP,
Trasadingen, Switzerland) reaching 80% confluence. The
transfection mixture was obtained by mixing 24 μg of EGFP-N1
plasmid DNA (Clontech, Basel, Switzerland) in 1.5 mL of
OptiMEM medium (Gibco Life Technologies, Basel, Switzer-
land) and 60 μL of Lipofectamine 2000 reagent in 1.5 mL of
OptiMEM medium. After 20 min of incubation at room temp-
erature (RT) the transfection mixture was added to the cells.
The transfection eﬃciency calculated at 20 h after transfection
was approximately 80%.
For MALDI-MS fingerprinting of melanoma cells without Al
foil, the cells were washed with PBS, collected by centrifu-
gation and kept at −80 °C. Before MS experiments, PBS was
added to the cell pellets in order to have a final concentration
equal to 104 cells per μL. These samples were further deposited
on MALDI plates using matrix premixing or layer-by-layer
deposition approaches (for more details, see ESI-II†).
Fixation protocols
To fix cells with dehydrating agents, the aluminium foil with
adherent cells was submerged for 5–7 min in the cooled down
(−20 °C) solution of pure methanol (methanol protocol),
methanol/acetone (50%/50% v/v, methanol–acetone protocol)
or methanol/ethanol (50%/50% v/v, methanol–ethanol proto-
col). Cross-linking fixation was performed by placing the alu-
minium foil inside an ice-cold 4% formaldehyde solution for
15 min (formaldehyde protocol). To permeabilize cells fixed
with formaldehyde, the foil was additionally placed for 10 min
in methanol cooled down to −20 °C (formaldehyde–methanol
protocol). Thereafter, all fixed samples were submerged in de-
ionized water for 5 min and finally dried at RT. In order to
obtain the non-fixed samples adherent cells grown on alu-
minium foil were placed into the deionized water for 5 s and
then dried at RT.
MALDI experiments
Molecular mass fingerprints of melanoma cells were obtained
by a Microflex LRF MALDI-time-of-flight (TOF) instrument
(Bruker Daltonics, Bremen, Germany) operated in a positive
linear mode. Before each experiment, the samples on alu-
minium foil were positioned on a MALDI target plate by using
a double-sided tape and flattened by pressing it with a micro-
scopic glass slide. Thereafter, 1 µL of CytC aqueous solution
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(2 mg mL−1) was positioned onto each aluminium foil in a
cell-free region and dried at RT for the external calibration of
the TOF analyser by using its [M + H]+ and [M + 2H]2+ peaks.
Finally, 1 µL of the matrix solution was deposited over the cells
and the calibration spots and crystalized at RT. Calibration of
the instrument was performed separately for each cells-on-
aluminium sample. An average cell spectrum was collected from
500 random laser shots at 20 Hz laser frequency. The instru-
mental parameters were fixed as the following: laser attenuator
– 90% within the range of 30% to 70% laser intensity; delayed
ion extraction time – 400 ns; detector gain – 19.4×; electronic
gain – enhanced (100 mV). The ion source voltages were at the
optimized values: ion source 1 – 20.0 kV; ion source 2 – 18.5
kV; lens – 8.5 kV. The MS spectra were analysed by mMass –
Open Source Mass Spectrometry Tool (http://www.mmass.org).
Peaks with S/N ≥ 3 were considered as significant. A tolerance
of 500 ppm was set for identical peaks.
Results and discussion
The intact cell MALDI-MS approach is a simple method that
allows distinguishing diﬀerences in the mass spectra of dis-
tinct cell types without the need of performing the full pro-
teome identification. Sample preparation for the intact cell
MALDI-MS typically involves only washing of cells which are
directly cultured on the target plate, as was presented by Berg-
quist et al.19 The main limitations of this strategy are related to
the MALDI plate contamination, and the large consumption of
reagents due to the MALDI target plate size. To overcome these
problems and as an alternative to cell pellet collection
methods,11,20–23 we demonstrate for the first time the concept
of growing cells on a disposable thin aluminium foil for
MALDI-MS experiments. Previously the aluminium foil layer
has been shown as an ideal disposable substrate for
MALDI-MS presenting good sensitivity for the detection of pro-
teins and peptides.34 However, this approach has thus far not
yet been applied for whole cell analysis. In contrast to the on-
plate cell culturing, growing mammalian cells on a disposable
thin aluminium foil requires a smaller amount of both cells
and growth medium, and allows working with diﬀerent cell
types simultaneously by placing a few samples on the same
target plate (ESI-I†). Furthermore, adherent cells grown on alu-
minium foil can be easily transferred between various solu-
tions (e.g. washing and fixation solutions). However, it is of
note to mention that estimation of cell density in such
samples becomes diﬃcult due to the non-transparency and
strong light reflection of the foil. Therefore, equal and repro-
ducible cell culturing conditions are highly required.
Moreover, positioning the aluminium foil on the MALDI
target plate changes the distance that ions have to pass in the
TOF mass analyser, and thus the energy obtained by the ions
from the extraction/acceleration electric fields. Therefore, the
MALDI-TOF-MS instrument has to be calibrated for each
experiment, e.g. by analysing a spot of CytC positioned on the
same aluminium foil. An important step for MALDI-MS experi-
ments is the optimization of the sample ionization, which can
be significantly influenced by (i) the applied MALDI matrix, (ii)
the presence of salts in the sample and (iii) the application of
organic solvents. With the aim of optimizing the ionization
process of cellular proteins on aluminium foils, the MS-
spectra of WM-239 cells overexpressing EGFP (M = 26.9 kDa)
were collected for several matrix combinations (i.e. SA,
DHB and HCCA) and cell fixation protocols (i.e. formaldehyde,
formaldehyde–methanol, methanol, methanol–acetone and
methanol–ethanol). Additionally, non-fixed cells directly
washed with deionized water were also analysed by MALDI-MS
(Fig. 1).
Fixation is a process commonly used in biology that
eliminates the biological activity inside cells and tissues, but
preserves the cellular ultrastructure as well as proteins,
carbohydrates and other bio-active moieties in their original
spatial organization within the cells.35 Fixation procedures will
trap protein components in a matrix of insoluble proteins and
therefore, allows us to immobilize cells on a surface and to
wash them in order to remove salts present in the growth
medium without any risk of sample destruction. Conversely,
washing of intact cells without fixation should be performed
fast and gently in order to minimise the removal and dama-
ging of cells that can lead to a loss of intracellular protein
content. Nevertheless, previous studies indicate that fixation
can drastically aﬀect the final ionization eﬃciency and there-
fore, the most widely used biological fixation approaches were
tested here in order to determine the optimal one for the
intact cell MALDI-MS.
As can be seen from the spectra collected for diﬀerent
matrix and fixation combinations (Fig. 2), when HCCA or DHB
matrices were applied no ionization of molecules with mole-
cular weight higher than 15 kDa was observed irrespective of
the fixation method (Fig. 2 columns 2 and 3). Additionally,
poor ionization eﬃciency was also obtained when a DHB
matrix was used (Fig. 2 column 2), i.e. the highest number of
peaks was achieved when analysing methanol and methanol–
acetone fixed cell samples and was equal to 20. In contrast, the
SA matrix showed both the highest ionization eﬃciency and
number of detected species within an m/z range from 4000 to
40 000 (Fig. 2 column 1), i.e. up to 50 well resolved peaks can
be distinguished depending on the fixation protocol.
Indeed, the fixation protocol significantly influences the
results. For instance, formaldehyde fixation with and without
permeabilization was not suitable for the detection of mole-
cules with a molecular weight higher than 15 kDa (Fig. 2d and
g), while all types of alcohol fixation protocols (Fig. 2j, m and
p) and the non-fixed samples (Fig. 2a) allowed the detection of
species within the 25 000–40 000 m/z range. The latter can be
due to: (i) the diﬀerent nature of the formaldehyde and
alcohol fixation, i.e. chemical cross-linking and physical pre-
cipitation, respectively and (ii) additional cell membrane per-
meabilization by alcohols. Moreover, when working with
formaldehyde fixed cells, the molecular weight of the cross-
linked proteins might be too high and its concentration too
low to be detected by MALDI-MS.
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It is also of note to mention that the overexpressed EGFP
was only detected in non-fixed and methanol–acetone permea-
bilized cells (Fig. 2 red arrows). Despite a higher EGFP peak
intensity being observed in the non-fixed sample, the reprodu-
cibility of the signal under these experimental conditions was
low (vide infra).
Indeed, the MALDI-MS fingerprints obtained from a set of
non-fixed WM-239 cells-on-aluminium samples showed sig-
nificant diﬀerences in the ionization eﬃciency and MS spectra
(Fig. 3a). Thus, only 22 well-resolved peaks with S/N ≥ 3 can be
distinguished on the upper spectrum in Fig. 3a, while 37
peaks are presented on the lower one. The latter can be
explained by the strong influence of the salts present in the
analysed sample and the irreproducibility of the cell washing
step due to the time-restrictions when working with live cells.
Conversely, alcohol fixation results in a good reproducibility
of 32 resolved peaks with a signal to noise ratio ≥3 in all col-
lected spectra (Fig. 3b). Therefore, the intact cell MALDI-MS of
samples pretreated with a methanol–acetone solution can be
compared in a more reliable way.
The intact cell MALDI-MS fingerprints of the WM-239 cell
line with and without overexpressed EGFP are presented in
Fig. 3c. An additional peak corresponding to a molecular
weight equal to 26.9 kDa with a 3% relative abundance can be
clearly detected, confirming the potential ability of our
approach to detect diﬀerences in protein expression profiles in
whole cells.
Furthermore, the comparison of the intact cell MALDI-MS
on aluminium foil with the cell pellet collection approach
presented significant diﬀerences in the obtained MALDI-MS
fingerprints. The cell pellet fingerprints were obtained by
following two approaches: (i) premixing of the pellet with the
SA matrix20,21 and (ii) deposition of the pellet and matrix layer-
by layer.22 As a result, the fingerprints obtained by the premix-
ing approach presented better resolution (ESI-II†). Addition-
ally, no species with an m/z higher than 15 000 can be detected
for the cell pellet independently of the matrix deposition pro-
cedure, illustrating the better ionization of large molecules in
the case of cells grown on aluminium foil (Fig. 3d).
The optimized protocol for the intact cell MALDI-MS on
aluminium foil was further applied to characterize three mela-
noma cell lines, i.e. Sbcl2, WM-115 and WM-239 derived from
RGP, VGP and metastatic melanomas, respectively. In order to
characterize the reproducibility of the obtained fingerprints,
each of the cell type was grown in triplicate and thereafter,
three MALDI-MS spectra were collected from each of the
obtained samples. Further, all the collected spectra (i.e. 27
spectra in total) were analysed in terms of m/z and the inten-
sity of all characteristic peaks. As a result, MALDI-fingerprints
obtained from cells grown on aluminium foil presented high
reproducibility, when collected from the same sample (thus,
the standard deviation of the intensity of most of the peaks
was less than 5). However, significant variation of peak inten-
sity can be observed when comparing fingerprints from
diﬀerent samples (but for the same cell type), leading to high
values of standard deviation (i.e. up to 30). The last can be due
to some diﬀerences in cell density on the investigated surfaces.
A detailed list of all the characteristic peaks with their intensi-
ties and standard deviation as well as all the obtained spectra
are given in ESI-III.†
Fig. 1 Schematic representation of diﬀerent sample preparation protocols applied for MALDI-MS analysis of mammalian cells grown on disposable
aluminium foils.
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Comparison of the fingerprints collected from diﬀerent
cell lines (i.e. Sbcl2, WM-115 and WM-239) presented a very
similar peak distribution except for 2 peaks of m/z equal to
10 000 and 26 100. Thus, plotting the intensity of m/z equal
to 26 100 over 10 000 presents the possibility of diﬀerentiat-
ing all the investigated cell lines based on these peaks
(ESI-III and Fig. S7†). Indeed, the m/z equal to 10 000 was
only detected in the early stage melanoma cells (i.e. RGP and
VGP), but not in the metastatic stage cells (Fig. 4a and b).
Furthermore, the signal of 26 100 m/z was absent only in the
RGP stage cells.
It is also interesting to notice that the MALDI-MS finger-
prints obtained from pellets of diﬀerent cell types also present
some diﬀerences in the fingerprints of the investigated cell
Fig. 2 Optimization of the MALDI matrices and the cell ﬁxation protocols for obtaining characteristic MS ﬁngerprints of WM-239 melanoma cells
with an overexpressed EGFP. MALDI matrices were SA (a, d, g, j, m and p), DHB (b, e, h, k, n and q) and HCCA (c, f, i, l, o and r). Fixation protocols
were: non-ﬁxed cells, NF (a–c); formaldehyde, F (d–f ); formaldehyde–methanol, FM (g–i); methanol, M ( j–l); methanol–acetone, MA (m–o); and
methanol–ethanol, ME (p–r).
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Fig. 3 Reproducibility of the MS spectra obtained for non-ﬁxed (a) and methanol–acetone ﬁxed (b) WM-239 cells. The upper and lower spectra
represent MALDI-MS results for 2 samples prepared in the same way (i.e. culturing conditions, ﬁxation and washing). Characteristic MALDI-MS
ﬁngerprints of WM-239 cells without (upper spectrum) and with (lower spectrum) the overexpressed EGFP in the optimized conditions (i.e. metha-
nol–acetone ﬁxation protocol) are presented in (c). Comparison of the ﬁngerprints obtained from WM-239 cells grown on aluminium foil (upper
spectrum) and intact cell MALDI-MS of the cell pellet (lower spectrum; 104 cells per μL premixed with the matrix) are presented in (d). SA was
employed as the MALDI matrix in all the experiments.
Fig. 4 The characteristic MALDI-MS ﬁngerprint spectra obtained for Sbcl2, WM-115 and WM-239 melanoma cell lines representing cancer pro-
gression (RGP, VGP and metastatic, respectively). For better visualisation of the obtained MS spectra, the obtained full spectra are separated in two
m/z ranges (i.e. m/z intervals from 5000 to 19 000 and from 19 000 to 50 000), and data are presented as the following pairs: Sbcl2 vs. WM-115 (a)
and Sbcl2 vs. WM-239 (b). Experimental conditions: methanol/acetone ﬁxation protocol, SA matrix.
Paper Analyst





















































lines (ESI-IV†). However, no correlation of these results with
fingerprints on aluminium foil can be detected.
The fingerprints of melanoma cells grown on the alu-
minium foil were shown to be applicable in following the
diﬀerences between diﬀerent cell lines. Despite this method
not allowing the identification of the observed peaks, the com-
parison of our data with the previously published proteomic
characterization of melanoma cell lines could be interest-
ing.36,37 In the literature, northern blot analysis revealed a sig-
nificant expression of the S100 family protein mRNAs in the
early melanoma stages (i.e. Sbcl2 and WM-115), while a lower
level in the metastatic WM-239 cell line.36 The molecular
weight of S100 proteins is 10 kDa, which correlates well with
the characteristic MS peak with m/z equal to 10 000 observed
only with Sbcl2 and WM-115. On the other hand, the m/z =
26 100 peak may represent the transmembrane protein
V-ATPase B2 identified by Baruthio et al. using liquid chrom-
atography coupled to MS/MS.37 This protein was shown to be
characteristic for late primary and metastatic cancer stages (i.e.
WM-115 and WM-239), but not for early tumour cells (i.e.
Sbcl2) pointing to its usefulness as a potential cancer pro-
gression biomarker.37 The ability to follow its expression by
the detection of its characteristic peak at m/z = 26 100 using
the intact cell MALDI-MS approach was demonstrated for the
first time in the present study. Thus, the approach can be
potentially interesting for the investigation of cellular processes.
Conclusions
A fast and simple intact cell MALDI-MS approach was success-
fully implemented as a tool for mammalian cell fingerprinting.
For this purpose, diﬀerent adherently growing melanoma cell
lines were cultured on disposable aluminium foils, which
allowed their facile transfer to the MALDI target plate for con-
secutive analysis. The influence of a wide range of cell fixation
protocols (i.e. formalin-based and alcohol-based methods) as
well as the impact of diﬀerent MALDI matrices on the
obtained characteristic spectra were investigated. Optimization
of the intact cell MALDI-MS protocol was performed based on
the MS fingerprints of the melanoma WM-239 cell line with
and without overexpression of EGFP (molecular weight equal
to 26.9 kDa). We found that a methanol–acetone fixation pro-
tocol in combination with an SA matrix allowed the reliable
and reproducible detection of the recombinant EGFP. Further-
more, in comparison with the cell pellet collection method,
this approach presented a higher ionization eﬃciency of large
molecules. The optimized protocol was used to diﬀerentiate
melanoma cell lines derived from diﬀerent cancer stages, i.e.
RGP, VGP and metastatic cells.
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